Bal Krishna Mishra

4PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 20, 2026
KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.

|Jun 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

|Feb 23, 2026
Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.

Akhil Kapoor, Ajay Kumar Singh, Mahesh Chaudhary

|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study).

Akhil Kapoor, Anuj Gupta, Bipinesh Sansar

Pageof 1

Frequent Collaborators

4 joint publications

Akhil Kapoor

4 joint publications

Anuj Gupta

4 joint publications

Bipinesh Sansar

3 joint publications

Shashikant Patne